News

Top News Stories

News

Bristol-Myers Squibb buys Mirati for $4.8B, as pharma fixates on cancer drugs

By Ike Swetlitz and Nacha Cattan

Recommended Just For You

News Stories

October 09, 2023

October 09, 2023

October 09, 2023

October 06, 2023

October 06, 2023

October 06, 2023

October 05, 2023